Trials / Terminated
TerminatedNCT02425878
Ulipristal Acetate 10 mg and Asisted Reproduction
Uterine Fibroids: Impact of Ulipristal Acetate 10 mg on ART Results
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Instituto Valenciano de Infertilidad, IVI VALENCIA · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Demonstrate an 15% increase in the rate of clinical pregnancy in women with inoperable intramural fibroids not distorting the uterine cavity within a program OVD, after administration of uPA in a dose of 10 mg orally daily for 12 weeks
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ulipristal Acetate | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-10-19
- Primary completion
- 2016-05-31
- Completion
- 2016-05-31
- First posted
- 2015-04-24
- Last updated
- 2020-10-14
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02425878. Inclusion in this directory is not an endorsement.